AGBL2 and rheumatoid arthritis: This a cross-sectional design; therefore, it is unable to demonstrate the causality of any variable for the development of ILD in RA; however, our findings of the association between anti-CCP2 titers and the presence and severity of this complication are relevant for further studies in experimental models or longitudinal studies.